Items where authors include "van den Berg, L."

Article

McFarlane, R. orcid.org/0000-0001-7380-4219, Opie-Martin, S., Caravaca Puchades, A. et al. (26 more authors) (2025) Clinical trajectories of genetic variants in ALS: a European observational study within PRECISION-ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26 (sup 1). pp. 41-49. ISSN 2167-8421

Caravaca Puchades, A., McDonough, H.E., Al-Chalabi, A. et al. (26 more authors) (2025) Mapping the natural history of amyotrophic lateral sclerosis: time-to-event analysis of clinical milestones in the pan-European, population-based PRECISION-ALS cohort. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26 (sup1). pp. 8-19. ISSN 2167-8421

Sennfält, S., Al-Chalabi, A., Caravaca Puchades, A. et al. (26 more authors) (2025) Respiratory function, survival, and NIV prevalence over time in ALS - a PRECISION ALS study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26 (sup1). pp. 61-72. ISSN 2167-8421

McFarlane, R., Galvin, M., Heverin, M. et al. (19 more authors) (2023) PRECISION ALS—an integrated pan European patient data platform for ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 24 (5-6). pp. 389-393. ISSN 2167-8421

Opie-Martin, S., Iacoangeli, A., Topp, S.D. et al. (46 more authors) (2022) The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration. Nature Communications, 13 (1). 6901. ISSN 2041-1723

Al-Chalabi, A., Shaw, P. orcid.org/0000-0002-8925-2567, Leigh, P.N. et al. (6 more authors) (2019) Oral levosimendan in amyotrophic lateral sclerosis : a phase II multicentre, randomised, double-blind, placebo-controlled trial. Journal of Neurology, Neurosurgery & Psychiatry, 90 (10). pp. 1165-1170. ISSN 0022-3050

Rooney, J., Fogh, I., Westeneng, H.J. et al. (17 more authors) (2016) C9orf72 expansion differentially affects males with spinal onset amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery and Psychiatry. ISSN 0022-3050